USCA RIA’s ResMed RMD Stock Holding History

USCA RIA’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-17,464	Closed	-$780K	–	306
2014 Q1	$780K	Buy	+17,464	New	+$784K	0.28%	114

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

USCA RIA's RMD Position: Q2 2014 in Review

USCA RIA sold out of ResMed (RMD) in Q2 2014, closing a stake of 17,464 shares — an estimated $780K sold.

USCA RIA first reported a position in RMD in Q1 2014 and held it in 1 quarter. The position peaked at $780K in Q1 2014. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2014.

USCA RIA reported no remaining ResMed position as of Q2 2014 after selling out during the quarter.
USCA RIA sold 17,464 ResMed shares in Q2 2014, an estimated $780K.
USCA RIA first reported a position in ResMed in Q1 2014 and held it in 1 quarter.
USCA RIA's ResMed position peaked at $780K in Q1 2014.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2014.

Based on USCA RIA's 13F filing for Q2 2014, filed 28 Aug 2014.